Log in

  • References on Bio-HRT
    February 12, 2010 08:45

    • Scientific Literature on Bio-identical Hormones: 

    Authors: Campagnoli C, Abba C, Ambroggio S, Peris C.
    Title: Pregnancy, progesterone and progestins in relation to breast cancer risk.
    Citation: J Steroid Biochem Mol Biol. 2005 Oct 21; [Epub ahead of print]
    Pub. Date:
    10/21/2005
    Authors: Mirkin S, Wong BC, Archer DF.,
    Title: Effect of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Citation: Fertil Steril. 2005 Aug;84(2):485-91.
    Pub. Date:
    8/1/2005
    Authors: Ropponen A, Aittomaki K, Vihma V, Tikkanen MJ, Ylikorkala O.
    Title: Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy.
    Citation: J Clin Endocrinol Metab. 2005 Jun;90(6):3431-4. Epub 2005 Mar 22.
    Pub. Date:
    6/1/2005
     
    Authors: Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F., ,
    Title: "Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort."
    Citation: Int J Cancer. 2005 Apr 10;114(3):448-54
    Pub. Date:
    4/10/2005
    Authors: Matthews KA, Owens JF, Salomon K, Harris KF, Berga SL
    Title: Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women.
    Citation: Biol Psychol 2005 Apr;69(1):39-56. Epub 2005 Jan 4.
    Pub. Date:
    4/1/2005
    Authors: Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA
    Title: Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Citation: Climacteric 2005 Mar;8(1):63-70
    Pub. Date:
    3/1/2005
    Authors: Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.
    Title: KEEPS: The Kronos Early Estrogen Prevention Study.
    Citation: Climacteric. 2005 Mar;8(1):3-12.
    Pub. Date:
    3/1/2005
    Authors: Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Vacca F, Genazzani AR.
    Title: Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Citation: Maturitas. 2005 Feb 14;50(2):91-7.
    Pub. Date:
    2/14/2005
    Authors: Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC,
    Title: "Effect of estrogen therapy on gallbladder disease. "
    Citation: JAMA. 2005 Jan 19;293(3):330-9
    Pub. Date:
    1/19/2005
    Authors: Ropponen A, Aittomaki K, Tikkanen MJ, Ylikorkala O
    Title: Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy.
    Citation: J Clin Endocrinol Metab 2005 Jan;90(1):142-6. Epub 2004 Nov 2
    Pub. Date:
    1/1/2005
    Authors: Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    Title: Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Citation: J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.
    Pub. Date:
    12/15/2004
    Authors: Decensi A, Bonanni B, Baglietto L, et al.
    Title: A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Citation: Clin Cancer Res 2004 Jul 1;10(13):4389-97
    Pub. Date:
    7/1/2004
    Authors: Prifti S, Lelle I, Strowitzki T, Rabe T.
    Title: Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
    Citation: Gynecol Endocrinol. 2004 Jul;19(1):18-21.
    Pub. Date:
    7/1/2004
    Authors: Hermsmeyer RK, Mishra RG, Pavcnik D, Uchida B, Axhelm MK, Stanczyk FZ, Burry KA, Illingworth DR, Juan C, Nordt FJ
    Title: Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone.
    Citation: Ateriosacler thromb Vasc Biol 2004 May;24(5):955-61.
    Pub. Date:
    5/1/2004
    Authors: Nelson, H
    Title: Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
    Citation: JAMA 2004;291:1610-20
    Pub. Date:
    4/7/2004
    Authors: Minkin, MJ
    Title: Considerations in the choice of oral vs. transdermal hormone therapy: a review.
    Citation: J Reprod Med. 2004 Apr;49(4):311-20
    Pub. Date:
    4/1/2004
    Authors: Stahlberg, C, Pedersen, A, Lynge, E, Anderson, Z, Keiding, N, Hundrup, Y, Obel, E, Ottesen, B
    Title: Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Citation: Int. J. Cancer:109,721-727 (2004)
    Pub. Date:
    1/1/2004
    Authors: Rosano G, Vitale C, Silvestri A, Fini M
    Title: Metabolic and vascular effect of progestins in post-menopausal women ;Implications for cardioprotection
    Citation: Maturitas 46 Suppl 1:17-29.
    Pub. Date:
    12/10/2003
    Authors: Schindler A, Campagnoli C, Drukmann R, Huber J, Pasqualini J, Schweppe KW, Thijssen JH
    Title: Classification and pharmacology of progestins
    Citation: Maturitas 46 Suppl 1:7-16
    Pub. Date:
    12/10/2003
    Authors: Schindler A
    Title: Differential effects of progestins: European Progestin Club
    Citation: Maturitas 2003;46 Suppl 1:s3-s5
    Pub. Date:
    12/10/2003

    Authors: Birrell SN, Butler LM, Harris JM, Buchanan G, Tilley WD
    Title: Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.
    Citation: FASEB J 2007 Apr 5; Epub ahead of print
    Pub. Date: 4/5/2007 
    Authors: Ribot C, Tremollieres F
    Title: [Hormone replacement therapy in postmenopausal women: all the treatments are not the same.] TRANSLATION ATTACHED
    Citation: Gynecol Obstet Fertil 2007 Mar 26; [Epub ahead of print]
    Pub. Date: 3/26/2007 
    Authors: Xu et al.
    Title: Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
    Citation: Maturitas 2006 Sept 6 [Epub ahead of print]
    Pub. Date: 9/6/2006 
    Authors: Hyder SM
    Title: Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
    Citation: Endocr Relat Cancer. 2006 Sep;13(3):667-87.
    Pub. Date: 9/1/2006 
    Authors: Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Mark Cline J
    Title: Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Citation: Breast Cancer Res Treat 2006 Jul 14; [Epub ahead of print]
    Pub. Date: 7/14/2006 
    Authors: Moskowitz D
    Title: A Comprehensive Review of the Safety and Efficacy of Bioidentical Hormones for the Management of Menopause and Related Health Risks.
    Citation: Alternative Medicine Review 2006;11(3):208-223
    Pub. Date: 1/1/2006 
    Authors: Cirpan, Terek, Ozsener, Kanit, Pogun, Zekioglu, Yucebilgin
    Title: Proliferative effects of different hormone regimes on mammary glands in ovariectomized rats
    Citation: Eur J Gynecol Oncol. 2006 27(3):256-261.
    Pub. Date: 1/1/2006 
    Authors: Campagnoli C, Abba C, Ambroggio S, Peris C.
    Title: Pregnancy, progesterone and progestins in relation to breast cancer risk.
    Citation: J Steroid Biochem Mol Biol. 2005 Oct 21; [Epub ahead of print]
    Pub. Date: 10/21/2005 
    Authors: Mirkin S, Wong BC, Archer DF.,
    Title: Effect of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Citation: Fertil Steril. 2005 Aug;84(2):485-91.
    Pub. Date: 8/1/2005 
    Authors: Menendez JA, Oza BP, Colomer R, Lupu R.
    Title: The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Citation: Int J Oncol. 2005 Jun;26(6):1507-15.
    Pub. Date: 6/1/2005 
    Authors: Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R, Elizalde PV.
    Title: Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
    Citation: Mol Cell Biol. 2005 Jun;25(12):4826-40.
    Pub. Date: 6/1/2005 
    Authors: Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrion F.
    Title: Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
    Citation: J Steroid Biochem Mol Biol. 2005 May 20; [Epub ahead of print]
    Pub. Date: 5/20/2005 
    Authors: Jordan VC.
    Title: Medroxyprogesterone acetate and metastases: of mice and (wo)men.
    Citation: J Natl Cancer Inst. 2005 May 4;97(9):619-21.
    Pub. Date: 5/4/2005 
    Authors: Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F.
    Title: "Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. "
    Citation: Int J Cancer. 2005 Apr 10;114(3):448-54
    Pub. Date: 4/10/2005 
    Authors: Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.
    Title: KEEPS: The Kronos Early Estrogen Prevention Study.
    Citation: Climacteric. 2005 Mar;8(1):3-12.
    Pub. Date: 3/1/2005 
    Authors: Colditz GA,
    Title: Estrogen, estrogen plus progestin therapy, and risk of breast cancer.
    Citation: Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):909s-17s
    Pub. Date: 1/15/2005 
    Authors: Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    Title: Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Citation: J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.
    Pub. Date: 12/15/2004 
    Authors: Moskowitz D.
    Title: Comment on Bioidentical hormone therapy: a review". (and author reply)"
    Citation: Menopause. 2004 Nov-Dec;11(6 Pt 1):639; author reply 639-41.
    Pub. Date: 11/1/2004 
    Authors: Druckmann, R
    Title: Progestins and their effects on the breast.
    Citation: Maturitas. 2003 Dec 10;46 Suppl 1:S59-69
    Pub. Date: 12/10/2003 
    Authors: Franke, HR, Vermes, I
    Title: Differential effects of progestogens on breast cancer cell lines.
    Citation: Maturitas. 2003 Dec 10;46 Suppl 1:S55-8
    Pub. Date: 12/10/2003 
    Authors: Mueck, AO, Seeger, H, Wallwiener, D
    Title: Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Citation: Climacteric. 2003 Sep;6(3):221-7
    Pub. Date: 9/1/2003 
    Authors: Suparto IH, Williams JK, Cline JM, Anothony MS, Fox JL.
    Title: Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Citation: Am J Obstet Gynecol. 2003 May;188(5):1132-40.
    Pub. Date: 5/1/2003 
    Authors: Seeger, H, Wallwiener, D, Mueck, AO
    Title: The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Citation: Horm Metab Res. 2003 Feb;35(2):76-80
    Pub. Date: 2/1/2003 
    Authors: Greendale, GA, Reboussin, BA, Slone, S, Wasilauskas, C, Pike, MC, Ursin, G
    Title: Postmenopausal hormone therapy and change in mammographic density.
    Citation: J Natl Cancer Inst. 2003 Jan 1;95(1):30-7
    Pub. Date:

    1/1/2003 

     

    Scientific Articles on HRT from MedlinePlus and National Library of Medicine:

    1. Hormone Replacement Therapy (National Library of Medicine)
      ... hot flashes and vaginal dryness. Some women take hormone replacement therapy (HRT) to relieve these symptoms. HRT may also protect against osteoporosis. However, HRT also ...
      www.nlm.nih.gov/medlineplus/hormonereplacementtherapy.html - Health Topics
    2. Important Facts about Post Menopausal Hormone Replacement Therapy (HRT) (American College of Gastroenterology)
      ... of female hormones. What are the Benefits of HRT? HRT is beneficial for any disorder caused by ... lowering cholesterol levels. Patients Who are Candidates for HRT Treatment: post-menopausal women women who have had ...
      www.gi.org/patients/women/menop.asp - External Health Links
    3. Estrogen and Progestin (Hormone Replacement Therapy)
      ... Estrogen and progestin are two female sex hormones. Hormone replacement therapy works by replacing estrogen hormone that is no ... menopausal women. Progestin is added to estrogen in hormone replacement therapy to reduce the risk of uterine cancer in ...
      www.nlm.nih.gov/medlineplus/druginfo/meds/a601041.html - Drugs and Supplements
    4. Hormone therapy
      HRT; Estrogen replacement therapy; ERT; Hormone replacement therapy
      www.nlm.nih.gov/medlineplus/ency/article/007111.htm - Medical Encyclopedia
    5. Breast Cancer Decline Only Partly Due to Hormone Replacement Therapy
      Breast Cancer Decline Only Partly Due to HRT Drop in hormone replacement therapy doesn't fully explain the 7% falloff, researchers say HealthDay By Robert Preidt Tuesday , December 8, 2009 TUESDAY, ...
      www.nlm.nih.gov/medlineplus/news/fullstory_92759.html - News
    6. Hormone Replacement Therapy and Your Heart (Mayo Foundation for Medical Education and Research)
      ... e-mail address Sign up View past issues Hormone replacement therapy and your heart Are you taking — or considering — ... in the United States routinely recommended long-term hormone replacement therapy to postmenopausal women to treat menopausal symptoms and ...
      www.mayoclinic.com/.../WO00131/METHOD=print - External Health Links
    7. Hormone Replacement Therapy: Can It Cause Vaginal Bleeding? (Mayo Foundation for Medical Education and Research)
      ... mail address Sign up View past issues Question Hormone replacement therapy: Can it cause vaginal bleeding? I'm taking ... safer? Hormone therapy: Is it right for you? Hormone replacement therapy and your heart Premature ovarian failure Perimenopause Related ...
      www.mayoclinic.com/.../AN01208/METHOD=print - External Health Links
    8. Hormone Replacement Therapy Given to Protect Heart, Despite Lack of Proof
      HRT given to protect heart, despite lack of proof Reuters Health Thursday , November 26, 2009 NEW YORK ( ... percent of women with heart disease were taking hormone replacement therapy in 1999-2000, just 8 percent were in ...
      www.nlm.nih.gov/medlineplus/news/fullstory_92364.html - News
    9. Menopausal Hormone Replacement Therapy Use and Cancer From the National Institutes of Health (National Cancer Institute)
      Menopausal Hormone Replacement Therapy Use and Cancer Key Points Menopausal hormone use (sometimes referred to as hormone replacement therapy or postmenopausal hormone use) involves taking either estrogen ...
      www.cancer.gov/.../factsheet/Risk/menopausal-hormones - External Health Links
    Bookmark and Share   
    Filed under:

    RevivaMed Integrative Medicine, 7300 Girard Avenue, Suite 101
    La Jolla, CA 92037

    Gaslamp:
    711 4th Ave, #200
    San Diego, CA 92101

    Copyright© 2012 Revivamed. All Rights Reserved. Privacy Policy | HIPPA Disclaimer | Terms Of Use | Site Map